AU2017353410B2 - Early detection of preliminary stages of testicular germ cell tumors - Google Patents

Early detection of preliminary stages of testicular germ cell tumors Download PDF

Info

Publication number
AU2017353410B2
AU2017353410B2 AU2017353410A AU2017353410A AU2017353410B2 AU 2017353410 B2 AU2017353410 B2 AU 2017353410B2 AU 2017353410 A AU2017353410 A AU 2017353410A AU 2017353410 A AU2017353410 A AU 2017353410A AU 2017353410 B2 AU2017353410 B2 AU 2017353410B2
Authority
AU
Australia
Prior art keywords
mir
pcr
tin
biological sample
batch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017353410A
Other languages
English (en)
Other versions
AU2017353410A1 (en
Inventor
Gazanfer Belge
Arlo RADTKE
Meike SPIEKERMANN
Nina WINTER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mirdetect GmbH
Original Assignee
Mirdetect GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirdetect GmbH filed Critical Mirdetect GmbH
Publication of AU2017353410A1 publication Critical patent/AU2017353410A1/en
Application granted granted Critical
Publication of AU2017353410B2 publication Critical patent/AU2017353410B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2017353410A 2016-11-02 2017-11-02 Early detection of preliminary stages of testicular germ cell tumors Active AU2017353410B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16196813.6 2016-11-02
EP16196813 2016-11-02
PCT/EP2017/078079 WO2018083186A1 (en) 2016-11-02 2017-11-02 Early detection of preliminary stages of testicular germ cell tumors

Publications (2)

Publication Number Publication Date
AU2017353410A1 AU2017353410A1 (en) 2019-04-11
AU2017353410B2 true AU2017353410B2 (en) 2023-04-13

Family

ID=57223558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017353410A Active AU2017353410B2 (en) 2016-11-02 2017-11-02 Early detection of preliminary stages of testicular germ cell tumors

Country Status (9)

Country Link
US (1) US11643690B2 (enExample)
EP (1) EP3535417B9 (enExample)
JP (2) JP7391367B2 (enExample)
CN (1) CN109890979B (enExample)
AU (1) AU2017353410B2 (enExample)
CA (1) CA3038010A1 (enExample)
ES (1) ES2952061T3 (enExample)
PL (1) PL3535417T3 (enExample)
WO (1) WO2018083186A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116121372B (zh) * 2022-09-09 2025-09-19 清远市人民医院 一种鉴别中枢系统淋巴瘤和胶质母细胞瘤的miRNA标志物组合、试剂盒及应用
CN120519585B (zh) * 2025-07-23 2025-10-03 湖南工程学院 一种基于PER驱动Split G4/ThT级联检测睾丸生殖细胞瘤miRNA的探针体系及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101363057B (zh) 2008-09-09 2011-11-09 浙江理工大学 一种生物样本中miRNA绝对表达量的检测方法
US20120107825A1 (en) * 2010-11-01 2012-05-03 Winger Edward E Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna
CN104080911A (zh) * 2011-11-30 2014-10-01 不来梅大学 miRNA在胎盘组织中的表达
CN104844566B (zh) * 2014-12-12 2018-05-18 合肥中科普瑞昇生物医药科技有限公司 一种新型结构的激酶抑制剂
DK3289095T5 (da) 2015-04-29 2019-07-29 Mirdetect Gmbh Detektering af nukleinsyremolekyler
US10136952B2 (en) * 2016-06-16 2018-11-27 Zimmer, Inc. Soft tissue balancing in articular surgery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M. SPIEKERMANN, G. BELGE, N. WINTER, R. IKOGHO, T. BALKS, J. BULLERDIEK, K.-P. DIECKMANN: "MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker", ANDROLOGY, SCRIPTOR PUBLISHER APS, HOBOKEN, USA, vol. 3, no. 1, 1 January 2015 (2015-01-01), Hoboken, USA, pages 78 - 84, XP055285513, ISSN: 2047-2919, DOI: 10.1111/j.2047-2927.2014.00269.x *

Also Published As

Publication number Publication date
US11643690B2 (en) 2023-05-09
PL3535417T3 (pl) 2023-10-02
AU2017353410A1 (en) 2019-04-11
WO2018083186A1 (en) 2018-05-11
ES2952061T3 (es) 2023-10-26
CA3038010A1 (en) 2018-05-11
EP3535417B1 (en) 2023-06-07
EP3535417B9 (en) 2023-10-04
US20200056243A1 (en) 2020-02-20
EP3535417A1 (en) 2019-09-11
JP2019532653A (ja) 2019-11-14
JP7391367B2 (ja) 2023-12-05
ES2952061T9 (es) 2023-11-02
CN109890979B (zh) 2023-06-16
CN109890979A (zh) 2019-06-14
JP2022088555A (ja) 2022-06-14

Similar Documents

Publication Publication Date Title
DK2732052T3 (en) Diagnostic microRNA profiling in cutaneous T cell lymphoma (CTCL)
KR101987358B1 (ko) 신규한 간암 진단용 바이오 마커 및 이의 용도
US20200123606A1 (en) Rt-qpcr method for direct quantitative detection of circulating mirna
CN107858434B (zh) lncRNA在肝癌诊断以及预后预测中的应用
US20230304081A1 (en) Primer and probe design method, detection composition, and kit for mirna detection
JP2022088555A (ja) 前段階の精巣胚細胞腫瘍の早期発見
CN107299129B (zh) 循环核酸作为乳腺癌生物标志物的应用
AU2016256581B2 (en) Detection of nucleic acid molecules
CN106148500A (zh) 一体化微小rna荧光定量检测试剂盒及其应用
CN110295232A (zh) 用于结直肠癌的microRNA生物标记物
WO2014057279A1 (en) Micro-rna biomarkers for prostate cancer
HK40013273A (en) Early detection of preliminary stages of testicular germ cell tumors
HK40013273B (en) Early detection of preliminary stages of testicular germ cell tumors
RU2469323C2 (ru) Способ диагностики рака мочевого пузыря (варианты) и набор для его осуществления
HK1251262B (en) Detection of nucleic acid molecules
HK1251262A1 (en) Detection of nucleic acid molecules
Al-Temimi et al. EVALUATION OF MICRORNA-21 IN INVASIVE DUCTAL CARCINOMA IN COMPARISON TO CLINICOPATHOLOGICAL STATUS BY STEM-LOOP RT-PCR PROCEDURE.
BR112019005790B1 (pt) Método para detectar rnas pequenos ou proteínas associadas a rnas pequenos

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)